Andrew D. Linden, a Member of Norris McLaughlin, P.A., and Co-Chair of its Cannabis Law Industry Group, was quoted in the Law360 article, “Workplace Medical Pot Protections At Stake In NJ High Court.”

The article addresses a New Jersey Supreme Court argument regarding an employee protection case utilizing the Compassionate Use Medical Marijuana Act (CUMMA) and the Law Against Discrimination (LAD).» Read More

Employers in New Jersey and New York City need to review their drug testing policies and employment practices considering laws recently enacted to protect employees (and applicants) who are authorized to use medical marijuana under state medical marijuana statutes.

On July 2, 2019, New Jersey joined a handful of other states affording employment protections for job applicants and employees who are legally authorized medical marijuana patients. » Read More

On Friday, May 10, New York City adopted a law (Int. 1445-A) prohibiting employers, labor organizations, and employment agencies from conducting pre-employment drug testing for THC, the active ingredient in cannabis and marijuana. The law will become effective on May 10, 2020, which gives New York City employers one year to prepare.» Read More